| Name | Title | Contact Details |
|---|
A specialty pharmaceutical company focused on the development and commercialization of pharmaceutical technologies to meet important healthcare challenges
NeuBase is developing ultra precision genetic medicines targeting rare, monogenic diseases, therapeutic candidates for the treatment of myotonic dystrophy type 1 (DM1), Huntington`s disease (HD), and cancer-driving point mutations in KRAS G12V and G12D, which are involved in many tumor types and have historically been “undruggable.” for which there are no approved therapies, as well as more common genetic disorders, including cancers that are resistant to current therapeutic approaches. NeuBase`s pipeline includes
Diva Pharmaceuticals is a Upper Saddle River, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Boehringer Laboratories, LLC. is a family owned American medical technology company with headquarters in Phoenixville, Pennsylvania.
Hillsides is a premier provider dedicated to improving the overall well-being and functioning of vulnerable children, youth, and their families.